Ignite Creation Date:
2025-12-24 @ 1:30 PM
Ignite Modification Date:
2026-01-25 @ 5:20 PM
Study NCT ID:
NCT01466595
Status:
COMPLETED
Last Update Posted:
2018-09-10
First Post:
2011-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rifaximin as a Modulator of Microbial Translocation and Immune Activation
Sponsor:
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-06
First Submit QC Date:
None
Study First Post Date:
2011-11-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-09-03
Results First Submit QC Date:
None
Results First Post Date:
2013-11-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-10
Last Update Post Date:
2018-09-10
Last Update Post Date Type:
ACTUAL